Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume 48, Issue 4, Pages 568-576
Publisher
Informa UK Limited
Online
2016-06-20
DOI
10.1080/03602532.2016.1192642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative and Non-Oxidative Metabolomics of Ethanol
- (2016) Ricardo J. Dinis-Oliveira CURRENT DRUG METABOLISM
- Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity
- (2016) Ricardo Jorge Dinis-Oliveira DRUG METABOLISM REVIEWS
- Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)
- (2016) Patrick A. Forcelli et al. NEUROPHARMACOLOGY
- Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients
- (2016) Hsin-Chou Yang et al. PLoS Genetics
- Usos Lícito e Ilícito dos Fármacos
- (2016) Ricardo Jorge Dinis-Oliveira Acta Medica Portuguesa
- Methadone Pharmacogenetics
- (2015) Evan D. Kharasch et al. ANESTHESIOLOGY
- Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy
- (2015) Leonie Meemken et al. ANNALS OF PHARMACOTHERAPY
- Treatment of Neuropathic Pain
- (2015) Matthew T. Mendlik et al. Current Treatment Options in Neurology
- A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study
- (2015) John F. Carlquist et al. Molecular Diagnosis & Therapy
- Effects of methadone plus alcohol on cognitive performance in methadone-maintained volunteers
- (2015) Bethea A. Kleykamp et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Pharmacogenomics of methadone maintenance treatment
- (2014) Andrew A Somogyi et al. PHARMACOGENOMICS
- Assessment of CYP450 genetic variability effect on methadone dose and tolerance
- (2014) Hui-Ju Tsai et al. PHARMACOGENOMICS
- Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity
- (2014) Ricardo Jorge Dinis-Oliveira Bioanalysis
- Mechanism of Autoinduction of Methadone N-Demethylation in Human Hepatocytes
- (2013) Scott D. Campbell et al. ANESTHESIA AND ANALGESIA
- QTc Interval Screening in Methadone Treatment
- (2013) Mori J. Krantz ANNALS OF INTERNAL MEDICINE
- Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine
- (2013) David E Moody Expert Opinion on Drug Metabolism & Toxicology
- Functional Genetic Polymorphisms in CYP2C19 Gene in Relation to Cardiac Side Effects and Treatment Dose in a Methadone Maintenance Cohort
- (2013) Sheng-Chang Wang et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Forensic toxicology in drug-facilitated sexual assault
- (2013) Ricardo Jorge Dinis-Oliveira et al. TOXICOLOGY MECHANISMS AND METHODS
- 1H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention
- (2012) Yi Deng et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Interindividual Variability of Methadone Response
- (2012) Yongfang Li et al. Molecular Diagnosis & Therapy
- UGT2B7genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients
- (2012) Jia-Ni Tian et al. PHARMACOGENOMICS
- CYP2B6SNPs are associated with methadone dose required for effective treatment of opioid addiction
- (2011) Orna Levran et al. ADDICTION BIOLOGY
- Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects
- (2011) Eloise A. Gelston et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2B6 and OPRM1 gene variations predict methadone-related deaths
- (2010) Hannah Bunten et al. ADDICTION BIOLOGY
- Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation
- (2010) Yan Chang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- OPRM1 and CYP2B6 Gene Variants as Risk Factors in Methadone-Related Deaths
- (2010) H Bunten et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Collection of biological samples in forensic toxicology
- (2010) R. J. Dinis-Oliveira et al. TOXICOLOGY MECHANISMS AND METHODS
- Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
- (2010) Valerie A. Gruber et al. Current HIV/AIDS Reports
- Role of CYP2B6 in Stereoselective Human Methadone Metabolism
- (2009) Rheem A. Totah et al. ANESTHESIOLOGY
- Opioid use affects antioxidant activity and purine metabolism: preliminary results
- (2009) Paolo Mannelli et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment
- (2008) Mohammad-Reza Shiran et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started